Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Infectious Diseases

• Publication date

  1995-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INFDIS/172.2.577PMID 7622910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense?

  1995cited by this paper
• Influence of IL-1 receptor blockade on the human response to endotoxemia.

  1995cited by this paper
• Slow release of soluble TNF receptors by monocytes in vitro.

  1994influential reference
• Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

  1994cited by this paper
• Tissue distribution and clearance of soluble murine TNF receptors in mice.

  1994cited by this paper
• Cytokine combinations increase p75 tumor necrosis factor receptor binding and stimulate receptor shedding in rheumatoid synovial fibroblasts.

  1994cited by this paper
• Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humans.

  1994cited by this paper
• Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

  1994cited by this paper
• Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia.

  1994cited by this paper
• Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.

  1993cited by this paper
• LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.

  1993cited by this paper
• Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans.

  1993cited by this paper
• Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

  1992cited by this paper
• Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.

  1992cited by this paper
• Comparison between effects of interleukin-1 alpha administration and sublethal endotoxemia in primates.

  1991cited by this paper
• Interleukin-1 and interleukin-1 antagonism.

  1991cited by this paper

• Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.

  2013cites this paper
• Proinflammatory and Anti-Inflammatory Cytokines as Mediators of Gram-Negative Sepsis

  2003cites this paper
• RELATIVE CYTOKINE AND CYTOKINE INHIBITOR PRODUCTION BY MONONUCLEAR CELLS AND NEUTROPHILS

  2003cites this paper
• Involvement of Pro- and Anti-Inflammatory Cytokines in Sepsis

  2002cites this paper
• Tumor Necrosis Factor-cw Induces Activation of Coagulation and Fibrinolysis in Baboons Through an Exclusive Effect on the p 55 Receptor

  2002cites this paper
• Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: Relation to disease severity, multiple organ dysfunction, and mortality

  2000cites this paper
• Soluble TNF receptors

  1999cites this paper
• Revisiting the role of tumor necrosis factor alpha and the response to surgical injury and inflammation.

  1998cites this paper
• Nutritional modulation of immunity and the inflammatory response.

  1998cites this paper
• Non-Human Primate Models of Sepsis

  1998cites this paper
• Role of cytokines in sepsis.

  1997cites this paper
• Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor.

  1996cites this paper
• Immunity to infection

  1996cites this paper
• Soluble receptors for cytokines and growth factors.

  1996cites this paper
• Endogenous IL-10 protects mice from death during septic peritonitis.

  1995cites this paper